Načítá se...
Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
Antibody-drug conjugates (ADCs) are a class of highly potent biopharmaceutical drugs generated by conjugating cytotoxic drugs with specific monoclonal antibodies through appropriate linkers. Specific antibodies used to guide potent warheads to tumor tissues can effectively reduce undesired side effe...
Uloženo v:
| Vydáno v: | Molecules |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6152078/ https://ncbi.nlm.nih.gov/pubmed/28763044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules22081281 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|